FDA clears blood test to aid evaluation for Alzheimer's disease
https://medicine.washu.edu/news/fda-clears-blood-test-to-aid-evaluation-for-alzheimers-disease/
WashU Medicine
FDA clears blood test to aid evaluation for Alzheimer’s disease | WashU Medicine
The blood-based biomarker test is based on technology developed at WashU Medicine by Randall Bateman, MD, and David Holtzman, MD.
August 24, 2026 36 1
